8 completed, 3 terminated. 11 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Completed 8, Terminated 3 |
Follow Warner Chilcott: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy Estradiol Vaginal Capsule (EVC), Placebo - Vulvovaginal Atrophy, Menopause | Phase 2 | Completed | Warner Chilcott | 203 | 2016-02-15 | 2017-08-23 |
| Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia WC3055, Placebo - Benign Prostatic Hyperplasia | Phase 2 | Completed | Warner Chilcott | 796 | 2013-08-01 | 2015-06-29 |
| Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction WC3036-11F/Alprostadil in Vehicle 2.5%, WC3036-12F/Alprostadil in Vehicle 0.5%, WC3036-13P/Vehicle Only 0.5% - Erectile Dysfunction | Phase 2 | Terminated | Warner Chilcott | 16 | 2013-02-01 | 2014-08-12 |
| Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure placebo, testosterone - Heart Failure | Phase 2 | Terminated | Warner Chilcott | 17 | 2009-07-01 | 2012-01-13 |
| Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal Women 150 mg, 75 mg, 100 mg - Postmenopausal Osteoporosis | Phase 2 | Completed | Warner Chilcott | 205 | 2009-05-01 | 2015-06-29 |
| A Two-week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Years) With Neurogenic Detrusor Overactivity Darifenacin - Neurogenic Detrusor Overactivity | Phase 2 | Terminated | Warner Chilcott | 35 | 2008-10-07 | 2022-06-09 |
| Treatment of Moderate to Severe Facial Acne Vulgaris Doxycycline 0.6 mg/kg/day, Doxycycline 1.2 mg/kg/day, Doxycycline 2.4 mg/kg/day - Acne Vulgaris | Phase 2 | Completed | Warner Chilcott | 257 | 2008-02-01 | 2013-04-22 |
| Asacol Acute Diverticulitis(DIVA)Study Mesalamine, Probiotic, Placebo - Diverticulitis | Phase 2 | Completed | Warner Chilcott | 117 | 2007-11-01 | 2013-04-22 |
| Assess the Safety, Efficacy, and Pharmacokinetics of Immediate and Delayed Release Weekly Risedronate risedronate - Postmenopausal Women | Phase 2 | Completed | Warner Chilcott | 181 | 2006-07-01 | 2012-01-13 |
| Study of Bleeding With Extended Administration of an Oral Contraceptive Norethindrone 1 mg / ethinyl estradiol 20 mcg - Contraception | Phase 2 | Completed | Warner Chilcott | 207 | 2006-06-01 | 2008-05-08 |
| Safety, Pharmacokinetics, and Efficacy of 100, 150, and 200 mg Risedronate Administered to Women With Low BMD risedronate, experimental - Postmenopausal | Phase 2 | Completed | Warner Chilcott | 370 | 2004-04-01 | 2013-04-17 |
Acne Vulgaris (1) · Diverticulitis (1) · Dyspareunia (1) · Erectile Dysfunction (1) · Heart Failure (1) · Meningomyelocele (1) · Osteoporosis, Postmenopausal (1) · Prostatic Hyperplasia (1) · Spinal Cord Injuries (1) · Urinary Bladder, Overactive (1)
Risedronic Acid (2) · Anti-Bacterial Agents (1) · Doxycycline (1) · Ethinyl Estradiol (1) · Mesalamine (1) · Norethindrone (1) · Nutrition Assessment (1) · Probiotics (1) · Testosterone (1) · darifenacin (1)
United States (11) · Canada (1) · Colombia (1) · Croatia (1) · Netherlands (1) · Poland (1)
Herman Ellman, MD (3) · Vilma Sniukiene, MD (2) · Ana Balske, MD, PhD (1) · Angelo Secci, MD (1) · Chantell Wilson, PhD (1) · John Beary, MD (1) · Jose Brum, MD (1) · Lu A Sun, MD, PhD (1)